Valuation: ResMed, Inc.

Market Cap 3.3TCr 2.82TCr 2.63TCr 2.42TCr 4.54TCr 3,15300Cr 4.63TCr 31TCr 12TCr 1,58000Cr 12TCr 12TCr 5,23200Cr P/E 2027 *
19.8x
P/E 2028 * 17.9x
Enterprise Value 3.2TCr 2.74TCr 2.56TCr 2.35TCr 4.41TCr 3,06200Cr 4.5TCr 30TCr 12TCr 1,53500Cr 12TCr 12TCr 5,08100Cr EV / Sales 2027 *
5.5x
EV / Sales 2028 * 5.04x
Free-Float
37.57%
Yield 2027 *
1.16%
Yield 2028 * 1.28%
1 day+1.56%
1 week+2.58%
Current month+9.13%
1 month+17.59%
3 months+10.18%
6 months-11.71%
Current year-4.41%
1 week 218.66
Extreme 218.655
232.99
1 month 190.21
Extreme 190.21
232.99
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/08/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
05/08/26 Sell

Founder

-8,000 0.0055%
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+1.56%+2.58%-20.15%+38.80% 3.3TCr
-0.91%+5.71%+28.55%+16.84% 23TCr
-0.12%+6.56%+5.80%-13.76% 15TCr
+0.84%-4.64%-19.93%+31.24% 13TCr
+0.96%-3.99%-52.70%-1.31% 7.15TCr
+0.08%-2.34%+10.23%+17.20% 5.18TCr
+0.46%+1.32%-16.66%-12.42% 5.18TCr
+0.61%+6.03%+34.43%+32.49% 4.41TCr
-0.05%-2.41%+38.49%+50.55% 3.98TCr
+0.45%+0.81%+1.55%+7.71% 3.35TCr
Average +0.38%+0.49%+0.96%+16.73% 8.42TCr
Weighted average by Cap. +0.07%+1.36%+3.81%+13.17%

Financials

2027 *2028 *
Net sales 581.81Cr 498.14Cr 464.78Cr 426.48Cr 801.37Cr 56TCr 817.15Cr 5.51TCr 2.15TCr 28TCr 2.18TCr 2.14TCr 92TCr 619.85Cr 530.72Cr 495.17Cr 454.36Cr 853.78Cr 59TCr 870.58Cr 5.87TCr 2.29TCr 30TCr 2.33TCr 2.28TCr 98TCr
Net income 162.86Cr 139.44Cr 130.1Cr 119.38Cr 224.32Cr 16TCr 228.73Cr 1.54TCr 601.64Cr 7.81TCr 611.49Cr 598.19Cr 26TCr 178.22Cr 152.59Cr 142.37Cr 130.64Cr 245.48Cr 17TCr 250.31Cr 1.69TCr 658.39Cr 8.55TCr 669.18Cr 654.62Cr 28TCr
Net Debt -95Cr -81Cr -76Cr -69Cr -130.48Cr -9.06TCr -133.04Cr -897.72Cr -349.95Cr -4.54TCr -355.68Cr -347.94Cr -15TCr -168.64Cr -144.39Cr -134.72Cr -123.61Cr -232.28Cr -16TCr -236.85Cr -1.6TCr -622.99Cr -8.09TCr -633.2Cr -619.42Cr -27TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
11,370
Date Price Change Volume
21/26/21 $230.59 +0.94% 1,41,721
20/26/20 $228.44 -0.96% 12,85,692
19/26/19 $230.65 +4.85% 12,09,808
18/26/18 $219.98 -0.18% 12,95,889
17/26/17 $220.37 -1.82% 14,53,880
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
228.44USD
Average target price
245.50USD
Spread / Average Target
+7.47%

Quarterly revenue - Rate of surprise